Currently accepted at: Journal of Medical Internet Research
Date Submitted: Nov 8, 2025
Date Accepted: Aug 14, 2026
This paper has been accepted and is currently in production.
It will appear shortly on 10.2196/87405
The final accepted version (not copyedited yet) is in this tab.
Beyond Accuracy: A Multidimensional Comparative Evaluation of ChatGPT, Gemini, and DeepSeek for Deep Brain Stimulation Patient Education
ABSTRACT
Background:
High-quality patient education for Deep Brain Stimulation (DBS) is crucial. While Large Language Models (LLMs) offer new information channels, their comparative quality in this high-risk neurosurgical field remains unknown, particularly regarding the complex trade-offs between scientific accuracy, patient comprehensibility, and empathy.
Objective:
This study conducted a multidimensional comparative evaluation of three mainstream LLMs (ChatGPT 5.0, Gemini 2.5, and DeepSeek 3.2) to assess their performance, safety, and suitability for DBS patient education.
Methods:
We constructed a standardized set of 50 Frequently Asked Questions (FAQs) derived from official guidelines and patient forums. Each LLM generated independent responses, yielding 150 total texts. A blinded review panel of 10 experts (8 neurosurgeons and 2 health communication specialists) evaluated the responses using a 5-point Likert scale across five dimensions. Subjective scores were analyzed using Linear Mixed-Effects Models (LMMs) to account for repeated measures; objective Flesch-Kincaid readability tests used the same architecture.
Results:
Significant differences emerged across ALL five dimensions (P < .001). ChatGPT achieved the highest Accuracy (Mean = 4.68, 95% CI [4.52, 4.84]), significantly outperforming Gemini (Mean = 4.20, 95% CI [4.04, 4.36]; Cohen's d = -1.21). DeepSeek achieved the highest Relevance (Mean = 4.78, 95% CI [4.66, 4.90]), while Gemini scored lowest (Mean = 4.31, 95% CI [4.19, 4.43]; d = -1.19 vs. DeepSeek). ChatGPT scored highest in Completeness (Mean = 4.90, 95% CI [4.77, 5.00]) but was rated lowest for subjective Comprehensibility (Mean = 3.98, 95% CI [3.71, 4.25]) and Humanistic Care (Mean = 3.40, 95% CI [3.17, 3.63]). Conversely, DeepSeek and Gemini demonstrated superior empathy; DeepSeek achieved the highest Humanistic Care score (Mean = 4.67, 95% CI [4.45, 4.90]; P < .001 vs. ChatGPT). Objective Flesch-Kincaid analysis corroborated these findings (P < .001): Gemini provided the easiest readability (Grade Level = 10.08, 95% CI [9.49, 10.67]), equivalent to a 10th-grade (high-school) reading level. DeepSeek followed at a high-school graduate level (Grade Level = 12.04, 95% CI [11.46, 12.63]). ChatGPT's responses required college-level reading proficiency (Grade Level = 13.51, 95% CI [12.93, 14.10]), posing a significant barrier for patients.
Conclusions:
LLMs are NOT interchangeable tools for patient education, with significant differences emerging across all dimensions including scientific accuracy itself. A critical behavioral trade-off exists: ChatGPT provides accurate and complete but complex and "cold" answers, making it unsuitable for direct patient queries. DeepSeek uniquely balances high relevance and empathy with near-comparable accuracy. Gemini provides superior readability but shows consistent deficits in accuracy, relevance, and completeness, rendering its unsupervised use for patients clinically risky. We propose a tiered implementation framework—utilizing high-accuracy models like ChatGPT as "clinician drafting assistants" and balanced empathetic models like DeepSeek as verified "initial patient resources"—to safely integrate AI into DBS patient care.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.